Neridronate

• 产品号: N6037
• CAS号: 79778-41-9
• 分子式: C7H19NO7P2
• 分子量: 291.175782
• 纯 度: ≥97% (NMR)

产品别名

• 标题: Neridronate
• IUPAC标准名: (7-amino-1-hydroxy-1-phosphonoheptyl)phosphonic acid
• IUPAC传统名: 7-amino-1-hydroxy-1-phosphonoheptylphosphonic acid
• 别名: Neridronic acid; 6-Amino-1-hydroxyhexylidene bisphosphonic acid; Nerixia

产品登记号

• CAS号: 79778-41-9
• PubChem SID: 24724553
• MDL号: MFCD00866995

产品性质

• 简要说明: may contain <1% (w/w) inorganic salts
• Empirical Formula (Hill Notation): C6H17NO7P2
• 纯度: ≥97% (NMR)
• 外观: white solid
• 溶解度: H2O: >5 mg/mL
• GHS警示词: Warning
• GHS危险声明: H302
• 欧盟危险性物质标志: 有害性(Harmful) (Xn)
• 个人保护装置: dust mask type N95 (US), Eyeshields, Gloves
• 危险公开号: 22
• 保存温度: 2-8°C
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
Neridronate is a bone resorption inhibitor. It is used to treat Osteogenesis Imperfecta, an "orphan disease" characterized by a fragility of the bone enough to be named the "illness of bones of crystal".

详细说明 (简体中文)

Biochem/physiol Actions
Neridronate is a bone resorption inhibitor. It is used to treat Osteogenesis Imperfecta, an "orphan disease" characterized by a fragility of the bone enough to be named the "illness of bones of crystal".